Purchase Short-Term Access
Brief Communication: Successful Treatment of Pure Red-Cell Aplasia with an Anti–Interleukin-2 Receptor Antibody (Daclizumab)
Elaine M. Sloand, MD; Phillip Scheinberg, MD; Jaroslaw Maciejewski, MD; Neal S. Young, MD
Annals of Internal Medicine 2006;144:181-185.
doi:10.7326/0003-4819-144-3-200602070-00006
Purchase Online access to this article for 24 hours
